ORIC Pharmaceuticals, Inc. ORIC
Set alert
9.88 USD +0.81 +8.93%
As of Nov 3, 1:52 PM ET
9.17 Day range 9.94
7.23 52-week range 14.68
- YTD
- +20.78%
- 1 year
- -22.14%
- Open
- 9.17
- Prev close
- 9.07
- Mkt cap
- 1.02B
- Vol
- 1.06M
- Avg vol
- 1.58M
- EPS
- -1.32
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.17
- High
- 9.94
- Forward P/E
- -7.87
- Beta
- 0.98
- Short ratio
- 11.16
- Inst. own
- 123.41%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 12, 2026
- 50-d avg
- 12.96
- 200-d avg
- 11.13
- 1y target
- 21.64
5Y chart
Events in this range
- Aug 12, 2025Earnings: -0.47; estimate -0.46; surprise -2.17%
- Nov 13, 2025Earnings: -0.33; estimate -0.41; surprise 19.51%
- Feb 23, 2026Earnings: -0.3; estimate -0.34; surprise 11.76%
- May 4, 2026Earnings: -0.34; estimate -0.32075; surprise -6%
- May 15, 2026Rating: Goldman Sachs · — → Buy
- Jun 8, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Aug 3, 2026Earnings: -0.38; estimate -0.35935; surprise -5.75%
- Aug 10, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Sep 23, 2026Rating: BTIG · — → Buy
- Oct 5, 2026Rating: Leerink Partners · — → Outperform
- Oct 14, 2026Rating: JP Morgan · Overweight → Overweight
Signals (98)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| SMA: Bullish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
Newest 20 of 98.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 21.64 +119.1% upside
Now 9.88
- Target (low)
- 14.00
- Target (mean)
- 21.64
- Target (high)
- 27.00
Ratings (0m) 16 15 buy · 1 hold · 0 sell
- Strong buy2
- Buy13
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 15
- 2 months ago 14
- 3 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.37887 | -0.45 – -0.32 | -0.33 | -14.8% | 0 | 0.0% | 13 |
| Next quarter | -0.39578 | -0.47 – -0.33713 | -0.30 | -31.9% | 0 | 0.0% | 13 |
| Current year | -1.49 | -1.64 – -1.25 | -1.47 | -1.3% | 0 | 0.0% | 13 |
| Next year | -1.67 | -1.91 – -1.37 | -1.49 | -12.4% | 0 | 0.0% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 5, 2026 | Leerink Partners | Initiated | — | Outperform |
| Sep 23, 2026 | BTIG | Initiated | — | Buy |
| Aug 10, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 8, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2026 | Goldman Sachs | Upgrade | — | Buy |
| May 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 1, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Mar 13, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 24, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 24, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 24, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jan 13, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jan 7, 2026 | Piper Sandler | Initiated | — | Overweight |
| Dec 8, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Dec 8, 2025 | Wedbush | Reiterated | Outperform | Outperform |
| Nov 20, 2025 | Evercore ISI Group | Initiated | — | Outperform |
| Nov 18, 2025 | Wolfe Research | Initiated | — | Peer Perform |
| Nov 18, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Nov 17, 2025 | Citigroup | Maintained | Buy | Buy |
| Nov 14, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 14, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 14, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 14, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 14, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 13, 2025 | Guggenheim | Reiterated | Buy | Buy |
| Jul 8, 2025 | Ladenburg Thalmann | Initiated | — | Buy |
| May 19, 2025 | JP Morgan | Maintained | Overweight | Overweight |
| May 9, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |